Covaxis

Covaxis is a combination vaccine designed to protect against multiple infectious diseases. It contains Aluminium Phosphate, Diphtheria Toxoid, Tetanus Toxoid, Pertussis Toxoid, and Pertussis Filamentous Haem. This vaccine is administered intramuscularly or subcutaneously.

Covaxis is used to prevent infections caused by diphtheria, tetanus, and pertussis. This vaccine is typically administered to individuals who require protection against these diseases. It is often used in children and adults who have not previously received the recommended vaccinations. The primary purpose of Covaxis is to stimulate the immune system to produce antibodies against these specific pathogens.

Common effects of Covaxis may include mild redness, swelling, or pain at the injection site. Some individuals may experience fever, fatigue, or general discomfort following vaccination. These effects are usually temporary and resolve on their own within a few days.

Covaxis should be administered by a healthcare professional. Individuals with a history of severe allergic reactions to any component of the vaccine should avoid its use. It is important to inform the healthcare provider about any current medications or health conditions before receiving the vaccine.

Covaxis may interact with certain medications or other vaccines. It is advisable to consult a healthcare provider before receiving Covaxis if you are taking any other medications. Additionally, individuals who have recently received another vaccine should discuss the timing of Covaxis administration with their healthcare provider.